Li et al. reported that CXCR2, a specific receptor for CXCL2/CXCL5, which are overexpressed in mesenchymal stromal cells (MSCs), promoted the migration of MSCs to sites of damage and achieved good therapeutic effects in an IBD mouse model (Li et al., 2021). Here, CXCL5 is linked to inflammatory bowel disease.